Provided by Tiger Trade Technology Pte. Ltd.

Astrana Health

24.48
+0.46001.92%
Post-market: 24.480.00000.00%16:20 EDT
Volume:267.53K
Turnover:6.52M
Market Cap:1.21B
PE:53.43
High:24.72
Open:24.32
Low:23.58
Close:24.02
52wk High:34.80
52wk Low:18.08
Shares:49.47M
Float Shares:44.09M
Volume Ratio:0.57
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4582
EPS(LYR):0.4582
ROE:4.49%
ROA:3.43%
PB:1.55
PE(LYR):53.43

Loading ...

Astrana Health Is Maintained at Buy by Truist Securities

Dow Jones
·
Mar 14

Astrana Health price target raised to $38 from $37 at Truist

TIPRANKS
·
Mar 13

Truist Lifts Price Target on Astrana Health to $38 From $37, Keeps Buy Rating

MT Newswires Live
·
Mar 13

OBBBA Threatens Astrana Health’s Revenue as Tighter Eligibility Rules Shrink Federally Funded Patient Base

TIPRANKS
·
Mar 13

A Look At Astrana Health (ASTH) Valuation After Rebrand And Mixed Shareholder Returns

Simply Wall St.
·
Mar 13

Astrana Health FY2025 adjusted EBITDA rose 21% to USD 205.42 million

Reuters
·
Mar 12

Astrana Health to Attend TD Cowen Annual Health Care Conference Fireside Chat

Reuters
·
Mar 04

Stock Track | Astrana Health Plummets 5.17% Intraday Amid Analyst Ratings and Broader Market Weakness

Stock Track
·
Mar 03

Analysts Conflicted on These Healthcare Names: Apogee Therapeutics (APGE), Astrana Health (ASTH) and Senseonics Holdings (SENS)

TIPRANKS
·
Mar 03

US Stocks Mixed Amid War Against Iran: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone

Benzinga
·
Mar 03

U.S. Small Caps Close Up; Astrana Health Climbs Highest

Dow Jones
·
Mar 03

Analysts’ Top Healthcare Picks: EyePoint Pharmaceuticals (EYPT), Astrana Health (ASTH)

TIPRANKS
·
Mar 03

Top Midday Gainers

MT Newswires Live
·
Mar 03

Stock Track | Astrana Health Soars 18.25% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance

Stock Track
·
Mar 02

Astrana Health Inc: Anticipates Reporting a Material Weakness in Co’s Internal Control Over Financial Reporting

THOMSON REUTERS
·
Mar 02

Astrana Health Inc: Files for Non Timely 10-K With U.S. SEC

THOMSON REUTERS
·
Mar 02

Astrana Health Inc: Believes Its Disclosure Controls and Procedures Were Not Effective, as of December 31, 2025

THOMSON REUTERS
·
Mar 02

Astrana Health Delays 2025 Annual Report Filing

Reuters
·
Mar 02

GUIDANCE: (ASTH) Astrana Health Expects 2026 Total Revenue Range $3.80B - $4.10B, vs. FactSet Est of $3.96B

MT Newswires Live
·
Mar 02

Astrana Health Inc Q4 Revenue USD 950.5 Million VS. Ibes Estimate USD 930.5 Million

THOMSON REUTERS
·
Mar 02